6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow Needles: new trials by email Literature Review of Needles trials Research Report on Needles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Teduglutide, Standard Medical Therapy, Syringe - Short Bowel Syndrome | Phase 3 | Completed | Shire | 10 | 2018-08-31 | 2021-05-11 |
| An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004 Teduglutide, Syringe, Needle - Short Bowel Syndrome | Phase 3 | Completed | Takeda | 11 | 2018-07-09 | 2023-03-15 |
| Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Teduglutide, Syringe, Needle - Short Bowel Syndrome | Phase 3 | Completed | Shire | 7 | 2018-07-06 | 2020-08-04 |
| Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) TED, SOC, Syringe - Short Bowel Syndrome | Phase 3 | Completed | Shire | 61 | 2017-01-09 | 2025-03-28 |
| Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension Bimatoprost SR, Sham: Applicator Without Needle, Active Comparator: Timolol 0.5% - Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Completed | Allergan | 528 | 2014-12-15 | 2021-07-28 |
| Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension Bimatoprost SR, Active Comparator: Timolol 0.5%, Sham: Applicator Without Needle - Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Completed | Allergan | 594 | 2014-12-15 | 2020-06-11 |
Short Bowel Syndrome (4) · Glaucoma, Open-Angle (2) · Ocular Hypertension (2)
Shire (3) · Allergan (2) · Takeda (1)
Italy (3) · United Kingdom (3) · United States (3) · Belgium (2) · Canada (2) · Finland (2) · Japan (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Colombia (1) · Czechia (1) · Denmark (1) · Egypt (1)
Margot Goodkin (1) · Marina Bejanian (1)
PMID 35643967, PMID 36378864, PMID 34724172, PMID 37364133, PMID 38873891, PMID 41858082
2014 (2), 2016 (1), 2017 (1)